⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 23, 2024Fortschritte der Neurologie · Psychiatrie

Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update

Udo Bonnet Georg Juckel

View at Publisher

Ask AI

Bookmark

Share

Abstract

Introduction Preclinically, fluvoxamine and other antidepressants (AD) exerted antiviral and anti-inflammatory properties also against SARS-COV-2. Therfore, It makes sense to test the clinical effect of AD against COVID-19 and Long COVID.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bonnet et al. (2024) studied this question.

synapsesocial.com/papers/68e579d7b6db643587519904 https://doi.org/10.1055/a-2374-2218

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Efficacy and Safety of Fluvoxamine in COVID-19 Patients: An Umbrella Review of Systematic Reviews and Meta-Analyses2025 · 1 citations
2Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after AnalysisCohort Study · 2023 · 6 citations
3Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases2024 · 2 citations
4Precision Medicine for COVID-19 Based on the Inflammatory Response2024 · 2 citations
5Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitroOriginal Research · 2022 · 69 citations

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial2024
Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection2022
Effectiveness and tolerability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study)2025
Flimsy but handy: Devising an algorithm as a novel approach to the pharmacotherapy of cocaine addictionFortschritte der Neurologie · Psychiatrie · 2025
Ofatumumab in der Behandlung der Multiplen Sklerose – Eine Übersicht der präklinischen und klinischen DatenFortschritte der Neurologie · Psychiatrie · 2024

FMore from Fortschritte der Neurologie · Psychiatrie

More from LWL-Universitätsklinikum Bochum